Identifícate
Grupos
Investigadores/as
Resultados
Biomedicina predictiva e investigación traslacional de las enfermedades respiratorias, cardiovasculares y metabólicas
BIOPRE
Hospital Duran i Reynals
Barcelona, España
Estás en
Colaboraciones
Hospital Duran i Reynals
Publicaciones en colaboración con investigadores/as de Hospital Duran i Reynals (3)
2024
Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib
Annals of Hematology
The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis
American Journal of Hematology
2023
Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors
Cancers, Vol. 15, Núm. 4
Contactar
Aviso Legal
Ayuda
translate
es
arrow_drop_down
translate
es
arrow_drop_down
ca
eu
gl
en
fr
de